| 0 |
PHARYNGEAL PUSTULE |
1 |
0.2000 |
| 1 |
URINARY TRACT SPASM |
1 |
0.0714 |
| 2 |
MAGNETIC RESONANCE IMAGING HEART |
1 |
0.0667 |
| 3 |
POSITRON EMISSION TOMOGRAM |
1 |
0.0417 |
| 4 |
SPECIALIST CONSULTATION |
1 |
0.0357 |
| 5 |
MEDIASTINAL FIBROSIS |
1 |
0.0238 |
| 6 |
VASCULAR ACCESS SITE THROMBOSIS |
1 |
0.0200 |
| 7 |
XEROPHTHALMIA |
8 |
0.0136 |
| 8 |
CRYOTHERAPY |
1 |
0.0135 |
| 9 |
RETROPERITONEAL CANCER |
1 |
0.0125 |
| 10 |
INTERCEPTED PRODUCT ADMINISTRATION ERROR |
89 |
0.0116 |
| 11 |
PARANEOPLASTIC DERMATOMYOSITIS |
1 |
0.0108 |
| 12 |
HER2 POSITIVE BREAST CANCER |
4 |
0.0107 |
| 13 |
METASTASES TO BONE MARROW |
5 |
0.0100 |
| 14 |
TRANSFERRIN DECREASED |
2 |
0.0098 |
| 15 |
OSTEOCHONDROSIS |
10 |
0.0086 |
| 16 |
ECHOCARDIOGRAM |
1 |
0.0079 |
| 17 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
257 |
0.0076 |
| 18 |
LABORATORY TEST |
1 |
0.0074 |
| 19 |
TESTICULAR FAILURE |
1 |
0.0073 |
| 20 |
GALLBLADDER CANCER STAGE IV |
1 |
0.0072 |
| 21 |
BREAST CELLULITIS |
2 |
0.0063 |
| 22 |
POST PROCEDURAL CELLULITIS |
1 |
0.0055 |
| 23 |
FOLATE DEFICIENCY |
6 |
0.0052 |
| 24 |
RETICULOCYTE COUNT DECREASED |
2 |
0.0046 |
| 25 |
PRODUCT STORAGE ERROR |
346 |
0.0039 |
| 26 |
SARCOID-LIKE REACTION |
1 |
0.0039 |
| 27 |
ASPARTATE AMINOTRANSFERASE DECREASED |
2 |
0.0038 |
| 28 |
HORMONE RECEPTOR POSITIVE BREAST CANCER |
1 |
0.0037 |
| 29 |
ATRIAL ENLARGEMENT |
1 |
0.0037 |
| 30 |
PRODUCT CLOSURE ISSUE |
2 |
0.0036 |
| 31 |
OCCUPATIONAL EXPOSURE TO PRODUCT |
23 |
0.0036 |
| 32 |
INTERCEPTED PRODUCT PREPARATION ERROR |
42 |
0.0034 |
| 33 |
HEART FAILURE WITH PRESERVED EJECTION FRACTION |
1 |
0.0034 |
| 34 |
VULVOVAGINAL DRYNESS |
10 |
0.0031 |
| 35 |
METABOLIC FUNCTION TEST ABNORMAL |
1 |
0.0030 |
| 36 |
BREAST HAEMORRHAGE |
1 |
0.0030 |
| 37 |
RECTAL STENOSIS |
1 |
0.0030 |
| 38 |
SCAN ABNORMAL |
1 |
0.0027 |
| 39 |
HYPERTENSIVE HEART DISEASE |
5 |
0.0027 |
| 40 |
BREAST RECONSTRUCTION |
1 |
0.0027 |
| 41 |
INTERCEPTED MEDICATION ERROR |
12 |
0.0026 |
| 42 |
EJECTION FRACTION ABNORMAL |
3 |
0.0024 |
| 43 |
PRODUCT ADMINISTRATION INTERRUPTED |
19 |
0.0024 |
| 44 |
HEPATIC HAEMORRHAGE |
2 |
0.0023 |
| 45 |
INTERCEPTED PRODUCT SELECTION ERROR |
3 |
0.0023 |
| 46 |
ADMINISTRATION SITE EXTRAVASATION |
2 |
0.0020 |
| 47 |
PRODUCT PREPARATION ERROR |
40 |
0.0019 |
| 48 |
CORONAVIRUS TEST POSITIVE |
2 |
0.0019 |
| 49 |
HEART FAILURE WITH REDUCED EJECTION FRACTION |
1 |
0.0019 |
| 50 |
PERIORBITAL CELLULITIS |
1 |
0.0019 |
| 51 |
EOSINOPHIL PERCENTAGE INCREASED |
1 |
0.0018 |
| 52 |
COLLAGEN DISORDER |
1 |
0.0017 |
| 53 |
EJECTION FRACTION |
1 |
0.0017 |
| 54 |
NASAL PRURITUS |
2 |
0.0016 |
| 55 |
BLOOD PRESSURE MEASUREMENT |
1 |
0.0016 |
| 56 |
AUTOIMMUNE COLITIS |
1 |
0.0016 |
| 57 |
NEUROPATHIC ARTHROPATHY |
1 |
0.0015 |
| 58 |
PRODUCT PREPARATION ISSUE |
10 |
0.0015 |
| 59 |
LEFT VENTRICULAR DYSFUNCTION |
10 |
0.0015 |
| 60 |
BRAIN CANCER METASTATIC |
1 |
0.0014 |
| 61 |
ECHOCARDIOGRAM ABNORMAL |
2 |
0.0014 |
| 62 |
RESPIRATORY SYNCYTIAL VIRUS TEST POSITIVE |
1 |
0.0014 |
| 63 |
CARDIAC SEPTAL DEFECT |
1 |
0.0014 |
| 64 |
REFUSAL OF TREATMENT BY PATIENT |
9 |
0.0014 |
| 65 |
GENERALISED ANXIETY DISORDER |
2 |
0.0014 |
| 66 |
PALLIATIVE CARE |
2 |
0.0013 |
| 67 |
VEIN COLLAPSE |
1 |
0.0013 |
| 68 |
MEAN CELL VOLUME DECREASED |
2 |
0.0013 |
| 69 |
PRODUCT KNOWLEDGE DEFICIT |
1 |
0.0013 |
| 70 |
BREAST CANCER RECURRENT |
4 |
0.0013 |
| 71 |
SKIN BACTERIAL INFECTION |
1 |
0.0012 |
| 72 |
MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED |
2 |
0.0012 |
| 73 |
INFUSION SITE OEDEMA |
1 |
0.0012 |
| 74 |
EXPOSURE TO SARS-COV-2 |
2 |
0.0012 |
| 75 |
PRODUCT TEMPERATURE EXCURSION ISSUE |
6 |
0.0012 |
| 76 |
MASTECTOMY |
2 |
0.0011 |
| 77 |
BONE CYST |
1 |
0.0011 |
| 78 |
INTRACRANIAL MASS |
1 |
0.0011 |
| 79 |
ANAL CANCER |
1 |
0.0010 |
| 80 |
BREAST ABSCESS |
1 |
0.0010 |
| 81 |
TEETH BRITTLE |
1 |
0.0010 |
| 82 |
INCORRECT DRUG ADMINISTRATION RATE |
4 |
0.0009 |
| 83 |
CLAUSTROPHOBIA |
1 |
0.0009 |
| 84 |
ARRHYTHMIA SUPRAVENTRICULAR |
1 |
0.0009 |
| 85 |
AORTIC DILATATION |
1 |
0.0009 |
| 86 |
ACUTE PULMONARY OEDEMA |
5 |
0.0009 |
| 87 |
LIGAMENT INJURY |
1 |
0.0009 |
| 88 |
KOUNIS SYNDROME |
2 |
0.0009 |
| 89 |
INTENTIONAL DOSE OMISSION |
25 |
0.0009 |
| 90 |
ROSACEA |
4 |
0.0009 |
| 91 |
DEVICE DISPENSING ERROR |
1 |
0.0008 |
| 92 |
EOSINOPHIL COUNT DECREASED |
2 |
0.0008 |
| 93 |
EJECTION FRACTION DECREASED |
13 |
0.0008 |
| 94 |
PRODUCT CONTAMINATION PHYSICAL |
2 |
0.0008 |
| 95 |
LIP HAEMORRHAGE |
1 |
0.0008 |
| 96 |
CANCER PAIN |
2 |
0.0008 |
| 97 |
MEAN CELL VOLUME INCREASED |
2 |
0.0008 |
| 98 |
BLOOD CHLORIDE DECREASED |
2 |
0.0008 |
| 99 |
SKIN ODOUR ABNORMAL |
3 |
0.0008 |
| 100 |
PRERENAL FAILURE |
1 |
0.0007 |
| 101 |
BLOOD ELECTROLYTES DECREASED |
1 |
0.0007 |
| 102 |
RESPIRATORY SYMPTOM |
2 |
0.0007 |
| 103 |
NORMOCYTIC ANAEMIA |
1 |
0.0007 |
| 104 |
EXCESSIVE EYE BLINKING |
1 |
0.0007 |
| 105 |
HAEMOLYTIC ANAEMIA |
6 |
0.0007 |
| 106 |
EMERGENCY CARE |
2 |
0.0007 |
| 107 |
MOUTH INJURY |
1 |
0.0007 |
| 108 |
ELECTROCARDIOGRAM T WAVE ABNORMAL |
1 |
0.0006 |
| 109 |
ONYCHOLYSIS |
1 |
0.0006 |
| 110 |
OSTEOSCLEROSIS |
1 |
0.0006 |
| 111 |
CARDIOVASCULAR INSUFFICIENCY |
1 |
0.0006 |
| 112 |
VEIN RUPTURE |
1 |
0.0006 |
| 113 |
LEFT VENTRICULAR FAILURE |
2 |
0.0006 |
| 114 |
FOOD CRAVING |
3 |
0.0006 |
| 115 |
FOOD POISONING |
3 |
0.0006 |
| 116 |
INFUSION RELATED REACTION |
36 |
0.0005 |
| 117 |
PNEUMOPERITONEUM |
1 |
0.0005 |
| 118 |
PROTEIN TOTAL DECREASED |
2 |
0.0005 |
| 119 |
SARS-COV-2 TEST POSITIVE |
7 |
0.0005 |
| 120 |
CARCINOEMBRYONIC ANTIGEN INCREASED |
1 |
0.0005 |
| 121 |
BICYTOPENIA |
1 |
0.0005 |
| 122 |
NAIL DISCOLOURATION |
2 |
0.0005 |
| 123 |
GENE MUTATION |
1 |
0.0005 |
| 124 |
SMALL INTESTINAL HAEMORRHAGE |
1 |
0.0005 |
| 125 |
CHILLS |
58 |
0.0005 |
| 126 |
ALANINE AMINOTRANSFERASE ABNORMAL |
1 |
0.0005 |
| 127 |
HYPERPYREXIA |
2 |
0.0005 |
| 128 |
INTESTINAL PERFORATION |
5 |
0.0004 |
| 129 |
FEAR OF DEATH |
1 |
0.0004 |
| 130 |
ACUTE HEPATIC FAILURE |
6 |
0.0004 |
| 131 |
ONYCHOCLASIS |
3 |
0.0004 |
| 132 |
ISCHAEMIA |
2 |
0.0004 |
| 133 |
NEUROLOGICAL DECOMPENSATION |
1 |
0.0004 |
| 134 |
ORAL SURGERY |
1 |
0.0004 |
| 135 |
COLORECTAL CANCER METASTATIC |
1 |
0.0004 |
| 136 |
PUSTULE |
1 |
0.0004 |
| 137 |
TUMOUR MARKER INCREASED |
2 |
0.0004 |
| 138 |
WEIGHT ABNORMAL |
1 |
0.0004 |
| 139 |
RASH VESICULAR |
2 |
0.0004 |
| 140 |
ERYSIPELAS |
2 |
0.0004 |
| 141 |
VASODILATATION |
1 |
0.0004 |
| 142 |
ACCIDENTAL EXPOSURE TO PRODUCT |
40 |
0.0004 |
| 143 |
APHTHOUS ULCER |
3 |
0.0004 |
| 144 |
VENTRICULAR DYSFUNCTION |
1 |
0.0004 |
| 145 |
UNEVALUABLE EVENT |
29 |
0.0004 |
| 146 |
FOLLICULITIS |
4 |
0.0004 |
| 147 |
LUNG OPACITY |
1 |
0.0004 |
| 148 |
ADVERSE REACTION |
5 |
0.0004 |
| 149 |
LARYNGOSPASM |
1 |
0.0004 |
| 150 |
PNEUMONITIS |
10 |
0.0004 |
| 151 |
ANAL HAEMORRHAGE |
1 |
0.0004 |
| 152 |
ATYPICAL FEMUR FRACTURE |
1 |
0.0004 |
| 153 |
NEUTROPHIL COUNT ABNORMAL |
1 |
0.0004 |
| 154 |
OXYGEN SATURATION ABNORMAL |
1 |
0.0004 |
| 155 |
HAEMATOLOGICAL MALIGNANCY |
1 |
0.0004 |
| 156 |
AUTONOMIC NERVOUS SYSTEM IMBALANCE |
1 |
0.0003 |
| 157 |
TOOTH DISCOLOURATION |
1 |
0.0003 |
| 158 |
INFUSION SITE REACTION |
1 |
0.0003 |
| 159 |
CENTRAL VENOUS CATHETERISATION |
1 |
0.0003 |
| 160 |
LIP DRY |
3 |
0.0003 |
| 161 |
DUODENITIS |
1 |
0.0003 |
| 162 |
DIARRHOEA HAEMORRHAGIC |
3 |
0.0003 |
| 163 |
INFUSION SITE PRURITUS |
1 |
0.0003 |
| 164 |
THERAPEUTIC RESPONSE CHANGED |
2 |
0.0003 |
| 165 |
LOOSE TOOTH |
1 |
0.0003 |
| 166 |
HEPATIC NEOPLASM |
1 |
0.0003 |
| 167 |
ARTERIOSCLEROSIS CORONARY ARTERY |
2 |
0.0003 |
| 168 |
CIRCULATORY COLLAPSE |
5 |
0.0003 |
| 169 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
5 |
0.0003 |
| 170 |
BREAST CANCER METASTATIC |
3 |
0.0003 |
| 171 |
SENSITIVE SKIN |
2 |
0.0003 |
| 172 |
LABORATORY TEST ABNORMAL |
8 |
0.0003 |
| 173 |
CARDIAC DYSFUNCTION |
1 |
0.0003 |
| 174 |
SNORING |
1 |
0.0003 |
| 175 |
CHEMOTHERAPY |
1 |
0.0003 |
| 176 |
ADVERSE EVENT |
24 |
0.0003 |
| 177 |
UNINTENTIONAL MEDICAL DEVICE REMOVAL |
3 |
0.0003 |
| 178 |
REHABILITATION THERAPY |
1 |
0.0003 |
| 179 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
6 |
0.0003 |
| 180 |
GASTROINTESTINAL INFLAMMATION |
2 |
0.0003 |
| 181 |
NEUROPATHY PERIPHERAL |
24 |
0.0003 |
| 182 |
POLYNEUROPATHY |
3 |
0.0003 |
| 183 |
PRODUCT ADMINISTRATION ERROR |
5 |
0.0002 |
| 184 |
RECURRENT CANCER |
1 |
0.0002 |
| 185 |
ANAPHYLACTOID REACTION |
1 |
0.0002 |
| 186 |
RED CELL DISTRIBUTION WIDTH INCREASED |
1 |
0.0002 |
| 187 |
DISEASE PROGRESSION |
28 |
0.0002 |
| 188 |
PRODUCT DOSE OMISSION ISSUE |
69 |
0.0002 |
| 189 |
VITAMIN D DECREASED |
2 |
0.0002 |
| 190 |
METASTATIC NEOPLASM |
1 |
0.0002 |
| 191 |
HORDEOLUM |
1 |
0.0002 |
| 192 |
ILL-DEFINED DISORDER |
14 |
0.0002 |
| 193 |
DIVERTICULUM INTESTINAL |
1 |
0.0002 |
| 194 |
NAIL DISORDER |
2 |
0.0002 |
| 195 |
COLD SWEAT |
4 |
0.0002 |
| 196 |
GINGIVAL SWELLING |
1 |
0.0002 |
| 197 |
LYMPHOCYTE COUNT DECREASED |
4 |
0.0002 |
| 198 |
BLOOD CREATINE INCREASED |
1 |
0.0002 |
| 199 |
CARDIOTOXICITY |
2 |
0.0002 |
| 200 |
VASCULAR DEVICE INFECTION |
1 |
0.0002 |
| 201 |
IMMUNE THROMBOCYTOPENIA |
1 |
0.0002 |
| 202 |
LOCALISED OEDEMA |
1 |
0.0002 |
| 203 |
NEPHROGENIC ANAEMIA |
1 |
0.0002 |
| 204 |
FEELING COLD |
6 |
0.0002 |
| 205 |
UMBILICAL HERNIA |
1 |
0.0002 |
| 206 |
BRONCHOSPASM |
3 |
0.0002 |
| 207 |
HAEMORRHOIDAL HAEMORRHAGE |
1 |
0.0002 |
| 208 |
HOSPICE CARE |
2 |
0.0002 |
| 209 |
PROTEIN URINE PRESENT |
1 |
0.0002 |
| 210 |
ANAPHYLACTIC REACTION |
11 |
0.0002 |
| 211 |
TOXIC SKIN ERUPTION |
2 |
0.0002 |
| 212 |
VULVOVAGINAL PRURITUS |
1 |
0.0002 |
| 213 |
BODY TEMPERATURE INCREASED |
4 |
0.0002 |
| 214 |
FAILURE TO THRIVE |
1 |
0.0002 |
| 215 |
TENDERNESS |
2 |
0.0002 |
| 216 |
CYANOSIS |
3 |
0.0002 |
| 217 |
GINGIVITIS |
1 |
0.0002 |
| 218 |
BACK INJURY |
2 |
0.0002 |
| 219 |
JAW DISORDER |
1 |
0.0002 |
| 220 |
TACHYCARDIA |
16 |
0.0002 |
| 221 |
HEART RATE ABNORMAL |
1 |
0.0002 |
| 222 |
MACULAR OEDEMA |
1 |
0.0002 |
| 223 |
OXYGEN SATURATION DECREASED |
10 |
0.0002 |
| 224 |
MITRAL VALVE INCOMPETENCE |
2 |
0.0002 |
| 225 |
DYSGEUSIA |
13 |
0.0002 |
| 226 |
NEUTROPHIL COUNT DECREASED |
7 |
0.0002 |
| 227 |
PRODUCT LABEL CONFUSION |
1 |
0.0002 |
| 228 |
BLOOD IRON DECREASED |
2 |
0.0002 |
| 229 |
DERMATITIS ACNEIFORM |
1 |
0.0002 |
| 230 |
TENSION |
1 |
0.0002 |
| 231 |
PHOTOPSIA |
1 |
0.0002 |
| 232 |
CHEST DISCOMFORT |
16 |
0.0002 |
| 233 |
PROCTALGIA |
1 |
0.0002 |
| 234 |
HAEMOGLOBIN ABNORMAL |
1 |
0.0002 |
| 235 |
INFUSION SITE PAIN |
2 |
0.0002 |
| 236 |
METASTASES TO CENTRAL NERVOUS SYSTEM |
2 |
0.0002 |
| 237 |
SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE |
1 |
0.0002 |
| 238 |
MUCOSAL INFLAMMATION |
4 |
0.0002 |
| 239 |
PULMONARY CONGESTION |
2 |
0.0002 |
| 240 |
HAEMATOCRIT DECREASED |
3 |
0.0002 |
| 241 |
APPETITE DISORDER |
1 |
0.0002 |
| 242 |
CARDIAC FAILURE ACUTE |
1 |
0.0001 |
| 243 |
ATRIOVENTRICULAR BLOCK COMPLETE |
1 |
0.0001 |
| 244 |
BLOOD BILIRUBIN INCREASED |
4 |
0.0001 |
| 245 |
ULCER HAEMORRHAGE |
1 |
0.0001 |
| 246 |
TACHYPNOEA |
2 |
0.0001 |
| 247 |
GINGIVAL BLEEDING |
2 |
0.0001 |
| 248 |
DROOLING |
1 |
0.0001 |
| 249 |
ADVERSE DRUG REACTION |
13 |
0.0001 |
| 250 |
LYMPHOEDEMA |
1 |
0.0001 |
| 251 |
HYPERTRANSAMINASAEMIA |
1 |
0.0001 |
| 252 |
PULMONARY TOXICITY |
1 |
0.0001 |
| 253 |
METASTASIS |
1 |
0.0001 |
| 254 |
THERAPY INTERRUPTED |
10 |
0.0001 |
| 255 |
RASH PUSTULAR |
1 |
0.0001 |
| 256 |
MAJOR DEPRESSION |
1 |
0.0001 |
| 257 |
UTERINE LEIOMYOMA |
1 |
0.0001 |
| 258 |
TRANSAMINASES INCREASED |
3 |
0.0001 |
| 259 |
HEPATOTOXICITY |
3 |
0.0001 |
| 260 |
HYDRONEPHROSIS |
1 |
0.0001 |
| 261 |
PAROSMIA |
1 |
0.0001 |
| 262 |
HEPATOCELLULAR CARCINOMA |
1 |
0.0001 |
| 263 |
OFF LABEL USE |
115 |
0.0001 |
| 264 |
HYPERTHERMIA |
1 |
0.0001 |
| 265 |
ACIDOSIS |
1 |
0.0001 |
| 266 |
DEVICE ADHESION ISSUE |
2 |
0.0001 |
| 267 |
HYPOALBUMINAEMIA |
1 |
0.0001 |
| 268 |
THERAPY PARTIAL RESPONDER |
2 |
0.0001 |
| 269 |
BRAIN FOG |
2 |
0.0001 |
| 270 |
CARDIAC FAILURE |
10 |
0.0001 |
| 271 |
ATRIAL FIBRILLATION |
12 |
0.0001 |
| 272 |
SHOCK HAEMORRHAGIC |
1 |
0.0001 |
| 273 |
PLATELET COUNT DECREASED |
13 |
0.0001 |
| 274 |
EPISTAXIS |
9 |
0.0001 |
| 275 |
AGEUSIA |
3 |
0.0001 |
| 276 |
CARDIOVASCULAR DISORDER |
3 |
0.0001 |
| 277 |
ILLNESS |
12 |
0.0001 |
| 278 |
BLOOD MAGNESIUM DECREASED |
1 |
0.0001 |
| 279 |
ANAEMIA |
22 |
0.0001 |
| 280 |
METASTASES TO LIVER |
2 |
0.0001 |
| 281 |
PRODUCT COMMUNICATION ISSUE |
1 |
0.0001 |
| 282 |
LUNG INFILTRATION |
1 |
0.0001 |
| 283 |
RASH |
49 |
0.0001 |
| 284 |
ISCHAEMIC STROKE |
2 |
0.0001 |
| 285 |
BACK PAIN |
26 |
0.0001 |
| 286 |
MYOSITIS |
1 |
0.0001 |
| 287 |
DRY MOUTH |
9 |
0.0001 |
| 288 |
DYSPNOEA |
62 |
0.0001 |
| 289 |
EXOSTOSIS |
1 |
0.0001 |
| 290 |
RESPIRATORY DISTRESS |
3 |
0.0001 |
| 291 |
TREMOR |
18 |
0.0001 |
| 292 |
UPPER RESPIRATORY TRACT INFECTION |
5 |
0.0001 |
| 293 |
FLANK PAIN |
1 |
0.0001 |
| 294 |
INCREASED APPETITE |
2 |
0.0001 |
| 295 |
AFFECT LABILITY |
1 |
0.0001 |
| 296 |
BLOOD PRESSURE SYSTOLIC INCREASED |
2 |
0.0001 |
| 297 |
HAEMORRHOIDS |
2 |
0.0001 |
| 298 |
SURGERY |
6 |
0.0001 |
| 299 |
THERAPY CHANGE |
1 |
0.0001 |
| 300 |
BLADDER DISORDER |
1 |
0.0001 |
| 301 |
BLOOD PRESSURE ABNORMAL |
2 |
0.0001 |
| 302 |
DIARRHOEA |
64 |
0.0001 |
| 303 |
STOMATITIS |
6 |
0.0001 |
| 304 |
DRY SKIN |
13 |
0.0001 |
| 305 |
TEMPERATURE INTOLERANCE |
1 |
0.0001 |
| 306 |
POOR VENOUS ACCESS |
1 |
0.0001 |
| 307 |
VENTRICULAR EXTRASYSTOLES |
1 |
0.0001 |
| 308 |
EYE DISCHARGE |
1 |
0.0001 |
| 309 |
PULMONARY HYPERTENSION |
2 |
0.0001 |
| 310 |
UNDERDOSE |
7 |
0.0001 |
| 311 |
WEIGHT FLUCTUATION |
1 |
0.0001 |
| 312 |
TRANSFUSION |
1 |
0.0001 |
| 313 |
KNEE ARTHROPLASTY |
2 |
0.0001 |
| 314 |
FULL BLOOD COUNT ABNORMAL |
1 |
0.0001 |
| 315 |
RETCHING |
2 |
0.0001 |
| 316 |
LIVER FUNCTION TEST INCREASED |
2 |
0.0001 |
| 317 |
ASTHENIA |
35 |
0.0001 |
| 318 |
PHARYNGITIS STREPTOCOCCAL |
1 |
0.0001 |
| 319 |
PRODUCT DISPENSING ERROR |
2 |
0.0001 |
| 320 |
CLOSTRIDIUM DIFFICILE INFECTION |
2 |
0.0001 |
| 321 |
TOOTH FRACTURE |
1 |
0.0001 |
| 322 |
FEBRILE NEUTROPENIA |
6 |
0.0001 |
| 323 |
LIP SWELLING |
3 |
0.0001 |
| 324 |
MALNUTRITION |
1 |
0.0001 |
| 325 |
BLOOD CALCIUM DECREASED |
1 |
0.0001 |
| 326 |
MYOCARDIAL ISCHAEMIA |
1 |
0.0001 |
| 327 |
MYOCARDITIS |
1 |
0.0001 |
| 328 |
PRODUCT SUBSTITUTION ISSUE |
5 |
0.0001 |
| 329 |
MUSCLE TWITCHING |
2 |
0.0001 |
| 330 |
ELECTROLYTE IMBALANCE |
1 |
0.0001 |
| 331 |
BONE PAIN |
5 |
0.0001 |
| 332 |
BLOOD PRESSURE FLUCTUATION |
2 |
0.0001 |
| 333 |
MALAISE |
36 |
0.0001 |
| 334 |
CYTOPENIA |
1 |
0.0001 |
| 335 |
CARDIOMEGALY |
1 |
0.0001 |
| 336 |
GENERALISED OEDEMA |
1 |
0.0001 |
| 337 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
2 |
0.0001 |
| 338 |
HOT FLUSH |
6 |
0.0001 |
| 339 |
ACNE |
6 |
0.0001 |
| 340 |
HEPATITIS |
2 |
0.0001 |
| 341 |
GASTROINTESTINAL DISORDER |
7 |
0.0001 |
| 342 |
HIATUS HERNIA |
1 |
0.0001 |
| 343 |
PALPITATIONS |
9 |
0.0001 |
| 344 |
CHEST PAIN |
14 |
0.0001 |
| 345 |
EAR INFECTION |
2 |
0.0001 |
| 346 |
QUALITY OF LIFE DECREASED |
1 |
0.0001 |
| 347 |
OEDEMA |
4 |
0.0001 |
| 348 |
NEUTROPENIA |
10 |
0.0001 |
| 349 |
INFLUENZA LIKE ILLNESS |
6 |
0.0001 |
| 350 |
ABDOMINAL PAIN UPPER |
15 |
0.0001 |
| 351 |
CENTRAL NERVOUS SYSTEM LESION |
1 |
0.0001 |
| 352 |
HYPOMAGNESAEMIA |
1 |
0.0001 |
| 353 |
WOUND |
2 |
0.0001 |
| 354 |
DEVICE OCCLUSION |
1 |
0.0001 |
| 355 |
HYPERTENSION |
15 |
0.0001 |
| 356 |
PRODUCT DOSE OMISSION IN ERROR |
2 |
0.0001 |
| 357 |
SINUS TACHYCARDIA |
1 |
0.0001 |
| 358 |
VOMITING |
33 |
0.0001 |
| 359 |
RED BLOOD CELL COUNT DECREASED |
2 |
0.0001 |
| 360 |
ANGINA PECTORIS |
2 |
0.0001 |
| 361 |
LETHARGY |
4 |
0.0001 |
| 362 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
2 |
0.0001 |
| 363 |
NAUSEA |
54 |
0.0001 |
| 364 |
ASCITES |
2 |
0.0001 |
| 365 |
RESPIRATORY DISORDER |
2 |
0.0001 |
| 366 |
BLOOD POTASSIUM DECREASED |
2 |
0.0001 |
| 367 |
LACRIMATION INCREASED |
2 |
0.0001 |
| 368 |
DIZZINESS |
33 |
0.0001 |
| 369 |
FATIGUE |
51 |
0.0001 |
| 370 |
BLOOD PRESSURE INCREASED |
10 |
0.0001 |
| 371 |
HYPERSENSITIVITY |
12 |
0.0001 |
| 372 |
LIMB DISCOMFORT |
2 |
0.0001 |
| 373 |
ANKLE FRACTURE |
1 |
0.0001 |
| 374 |
BREAST CANCER |
6 |
0.0001 |
| 375 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
13 |
0.0001 |
| 376 |
OBESITY |
1 |
0.0001 |
| 377 |
COVID-19 |
11 |
0.0001 |
| 378 |
DRUG INTOLERANCE |
6 |
0.0001 |
| 379 |
IMPAIRED HEALING |
2 |
0.0001 |
| 380 |
MULTIPLE FRACTURES |
1 |
0.0001 |
| 381 |
PHOTOSENSITIVITY REACTION |
1 |
0.0001 |
| 382 |
DEHYDRATION |
8 |
0.0001 |
| 383 |
FACE OEDEMA |
1 |
0.0001 |
| 384 |
FLUSHING |
6 |
0.0001 |
| 385 |
HEPATIC ENZYME INCREASED |
4 |
0.0001 |
| 386 |
HOSPITALISATION |
9 |
0.0001 |
| 387 |
THERAPY CESSATION |
3 |
0.0001 |
| 388 |
MUSCULOSKELETAL DISCOMFORT |
1 |
0.0001 |
| 389 |
INTENTIONAL PRODUCT USE ISSUE |
5 |
0.0001 |
| 390 |
NEUROTOXICITY |
1 |
0.0001 |
| 391 |
AMENORRHOEA |
1 |
0.0001 |
| 392 |
BLOOD TRIGLYCERIDES INCREASED |
1 |
0.0001 |
| 393 |
DRUG ERUPTION |
1 |
0.0001 |
| 394 |
GALLBLADDER DISORDER |
1 |
0.0001 |
| 395 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
10 |
0.0001 |
| 396 |
OSTEOMYELITIS |
1 |
0.0001 |
| 397 |
PELVIC PAIN |
1 |
0.0001 |
| 398 |
PYREXIA |
19 |
0.0001 |
| 399 |
OROPHARYNGEAL PAIN |
5 |
0.0001 |
| 400 |
CONJUNCTIVITIS |
1 |
0.0001 |
| 401 |
AGRANULOCYTOSIS |
1 |
0.0001 |
| 402 |
URTICARIA |
9 |
0.0001 |
| 403 |
PHOTOPHOBIA |
1 |
0.0001 |
| 404 |
DYSPNOEA EXERTIONAL |
2 |
0.0001 |
| 405 |
MYALGIA |
9 |
0.0001 |
| 406 |
SLEEP APNOEA SYNDROME |
1 |
0.0001 |
| 407 |
PULMONARY FIBROSIS |
1 |
0.0001 |
| 408 |
ACUTE RESPIRATORY FAILURE |
1 |
0.0001 |
| 409 |
HERNIA |
1 |
0.0001 |
| 410 |
EAR PAIN |
1 |
0.0001 |
| 411 |
ORAL HERPES |
1 |
0.0001 |
| 412 |
NASAL CONGESTION |
3 |
0.0001 |
| 413 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
2 |
0.0001 |
| 414 |
HEART RATE INCREASED |
5 |
0.0001 |
| 415 |
SYNCOPE |
5 |
0.0000 |
| 416 |
COUGH |
14 |
0.0000 |
| 417 |
CYTOKINE RELEASE SYNDROME |
1 |
0.0000 |
| 418 |
FEEDING DISORDER |
1 |
0.0000 |
| 419 |
PLEURAL EFFUSION |
3 |
0.0000 |
| 420 |
TASTE DISORDER |
1 |
0.0000 |
| 421 |
OEDEMA PERIPHERAL |
6 |
0.0000 |
| 422 |
HEADACHE |
29 |
0.0000 |
| 423 |
PRURITUS GENERALISED |
1 |
0.0000 |
| 424 |
WHITE BLOOD CELL COUNT DECREASED |
5 |
0.0000 |
| 425 |
AMNESIA |
3 |
0.0000 |
| 426 |
BLOOD CREATININE INCREASED |
3 |
0.0000 |
| 427 |
ACUTE KIDNEY INJURY |
7 |
0.0000 |
| 428 |
PERIPHERAL SWELLING |
7 |
0.0000 |
| 429 |
TOOTH DISORDER |
1 |
0.0000 |
| 430 |
RASH MACULO-PAPULAR |
1 |
0.0000 |
| 431 |
HYPOTENSION |
9 |
0.0000 |
| 432 |
ORAL PAIN |
1 |
0.0000 |
| 433 |
THERAPY NON-RESPONDER |
2 |
0.0000 |
| 434 |
PAIN IN EXTREMITY |
13 |
0.0000 |
| 435 |
MUSCLE SPASMS |
8 |
0.0000 |
| 436 |
TINNITUS |
2 |
0.0000 |
| 437 |
SHOCK |
1 |
0.0000 |
| 438 |
HYPOKALAEMIA |
2 |
0.0000 |
| 439 |
SEIZURE |
5 |
0.0000 |
| 440 |
PERICARDIAL EFFUSION |
1 |
0.0000 |
| 441 |
DISEASE RECURRENCE |
2 |
0.0000 |
| 442 |
BLOOD GLUCOSE DECREASED |
2 |
0.0000 |
| 443 |
LOCALISED INFECTION |
1 |
0.0000 |
| 444 |
CONSTIPATION |
9 |
0.0000 |
| 445 |
PRESYNCOPE |
1 |
0.0000 |
| 446 |
ALOPECIA |
8 |
0.0000 |
| 447 |
DYSPEPSIA |
4 |
0.0000 |
| 448 |
OSTEONECROSIS OF JAW |
1 |
0.0000 |
| 449 |
CELLULITIS |
2 |
0.0000 |
| 450 |
PRODUCT COMPLAINT |
1 |
0.0000 |
| 451 |
HYPOPHAGIA |
1 |
0.0000 |
| 452 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
1 |
0.0000 |
| 453 |
HYPERHIDROSIS |
5 |
0.0000 |
| 454 |
INFLAMMATION |
2 |
0.0000 |
| 455 |
DIPLOPIA |
1 |
0.0000 |
| 456 |
RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 457 |
NERVOUSNESS |
2 |
0.0000 |
| 458 |
MUSCULOSKELETAL PAIN |
2 |
0.0000 |
| 459 |
GASTRITIS |
1 |
0.0000 |
| 460 |
ASPARTATE AMINOTRANSFERASE INCREASED |
2 |
0.0000 |
| 461 |
BREAST CANCER FEMALE |
1 |
0.0000 |
| 462 |
PAIN OF SKIN |
1 |
0.0000 |
| 463 |
FREQUENT BOWEL MOVEMENTS |
1 |
0.0000 |
| 464 |
THROAT TIGHTNESS |
1 |
0.0000 |
| 465 |
RASH PRURITIC |
2 |
0.0000 |
| 466 |
MEDICATION ERROR |
2 |
0.0000 |
| 467 |
HAEMOPTYSIS |
1 |
0.0000 |
| 468 |
PANCYTOPENIA |
2 |
0.0000 |
| 469 |
THROMBOCYTOPENIA |
4 |
0.0000 |
| 470 |
HYPONATRAEMIA |
2 |
0.0000 |
| 471 |
PAIN IN JAW |
1 |
0.0000 |
| 472 |
ACUTE MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 473 |
WHEEZING |
2 |
0.0000 |
| 474 |
CORONARY ARTERY DISEASE |
1 |
0.0000 |
| 475 |
VERTIGO |
2 |
0.0000 |
| 476 |
ALANINE AMINOTRANSFERASE INCREASED |
2 |
0.0000 |
| 477 |
VISUAL IMPAIRMENT |
4 |
0.0000 |
| 478 |
WEIGHT DECREASED |
9 |
0.0000 |
| 479 |
SWOLLEN TONGUE |
1 |
0.0000 |
| 480 |
PARAESTHESIA |
5 |
0.0000 |
| 481 |
NIGHT SWEATS |
1 |
0.0000 |
| 482 |
PNEUMONIA |
10 |
0.0000 |
| 483 |
DECREASED APPETITE |
7 |
0.0000 |
| 484 |
BLOOD PRESSURE DECREASED |
2 |
0.0000 |
| 485 |
EXPIRED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 486 |
VIRAL INFECTION |
1 |
0.0000 |
| 487 |
FUNGAL INFECTION |
1 |
0.0000 |
| 488 |
SKIN DISORDER |
1 |
0.0000 |
| 489 |
GAIT INABILITY |
1 |
0.0000 |
| 490 |
ABDOMINAL DISCOMFORT |
5 |
0.0000 |
| 491 |
TYPE 2 DIABETES MELLITUS |
1 |
0.0000 |
| 492 |
GASTRIC DISORDER |
1 |
0.0000 |
| 493 |
ARTHRALGIA |
12 |
0.0000 |
| 494 |
DEVICE USE ERROR |
1 |
0.0000 |
| 495 |
NEOPLASM PROGRESSION |
1 |
0.0000 |
| 496 |
HAEMORRHAGE |
3 |
0.0000 |
| 497 |
RASH MACULAR |
1 |
0.0000 |
| 498 |
HYPERKALAEMIA |
1 |
0.0000 |
| 499 |
HYPOXIA |
1 |
0.0000 |
| 500 |
CEREBRAL HAEMORRHAGE |
1 |
0.0000 |
| 501 |
MYELOSUPPRESSION |
1 |
0.0000 |
| 502 |
INFECTION |
4 |
0.0000 |
| 503 |
RESPIRATORY FAILURE |
2 |
0.0000 |
| 504 |
ACCIDENTAL OVERDOSE |
1 |
0.0000 |
| 505 |
DYSURIA |
1 |
0.0000 |
| 506 |
EYE SWELLING |
1 |
0.0000 |
| 507 |
INTESTINAL OBSTRUCTION |
1 |
0.0000 |
| 508 |
COLITIS |
1 |
0.0000 |
| 509 |
CHRONIC KIDNEY DISEASE |
2 |
0.0000 |
| 510 |
PAIN |
16 |
0.0000 |
| 511 |
THROMBOSIS |
2 |
0.0000 |
| 512 |
BLINDNESS |
1 |
0.0000 |
| 513 |
LUNG NEOPLASM MALIGNANT |
1 |
0.0000 |
| 514 |
ERYTHEMA |
5 |
0.0000 |
| 515 |
OSTEOPOROSIS |
1 |
0.0000 |
| 516 |
CARDIAC ARREST |
2 |
0.0000 |
| 517 |
POLLAKIURIA |
1 |
0.0000 |
| 518 |
RENAL IMPAIRMENT |
2 |
0.0000 |
| 519 |
OSTEOARTHRITIS |
1 |
0.0000 |
| 520 |
URINARY TRACT INFECTION |
4 |
0.0000 |
| 521 |
PRURITUS |
9 |
0.0000 |
| 522 |
RECTAL HAEMORRHAGE |
1 |
0.0000 |
| 523 |
SEPTIC SHOCK |
1 |
0.0000 |
| 524 |
PULMONARY OEDEMA |
1 |
0.0000 |
| 525 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
1 |
0.0000 |
| 526 |
LOWER RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 527 |
NEPHROLITHIASIS |
1 |
0.0000 |
| 528 |
ABDOMINAL PAIN |
5 |
0.0000 |
| 529 |
CARDIAC DISORDER |
2 |
0.0000 |
| 530 |
ARRHYTHMIA |
1 |
0.0000 |
| 531 |
OCULAR HYPERAEMIA |
1 |
0.0000 |
| 532 |
PULMONARY EMBOLISM |
2 |
0.0000 |
| 533 |
MIGRAINE |
2 |
0.0000 |
| 534 |
PRODUCTIVE COUGH |
1 |
0.0000 |
| 535 |
FEELING ABNORMAL |
5 |
0.0000 |
| 536 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
1 |
0.0000 |
| 537 |
CONTUSION |
2 |
0.0000 |
| 538 |
INTERSTITIAL LUNG DISEASE |
1 |
0.0000 |
| 539 |
DRY EYE |
1 |
0.0000 |
| 540 |
LEUKOPENIA |
1 |
0.0000 |
| 541 |
SOMNOLENCE |
4 |
0.0000 |
| 542 |
FLUID RETENTION |
1 |
0.0000 |
| 543 |
SINUSITIS |
2 |
0.0000 |
| 544 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
1 |
0.0000 |
| 545 |
BRADYCARDIA |
1 |
0.0000 |
| 546 |
INSOMNIA |
5 |
0.0000 |
| 547 |
TREATMENT NONCOMPLIANCE |
1 |
0.0000 |
| 548 |
NECK PAIN |
1 |
0.0000 |
| 549 |
BLISTER |
1 |
0.0000 |
| 550 |
EYE PAIN |
1 |
0.0000 |
| 551 |
HERPES ZOSTER |
1 |
0.0000 |
| 552 |
NO ADVERSE EVENT |
3 |
0.0000 |
| 553 |
FEELING HOT |
1 |
0.0000 |
| 554 |
NASOPHARYNGITIS |
3 |
0.0000 |
| 555 |
GAIT DISTURBANCE |
3 |
0.0000 |
| 556 |
RHINORRHOEA |
1 |
0.0000 |
| 557 |
DEEP VEIN THROMBOSIS |
1 |
0.0000 |
| 558 |
DEVICE DIFFICULT TO USE |
1 |
0.0000 |
| 559 |
FALL |
5 |
0.0000 |
| 560 |
NEOPLASM MALIGNANT |
1 |
0.0000 |
| 561 |
VISION BLURRED |
2 |
0.0000 |
| 562 |
MEMORY IMPAIRMENT |
2 |
0.0000 |
| 563 |
BURNING SENSATION |
1 |
0.0000 |
| 564 |
DEVICE MALFUNCTION |
1 |
0.0000 |
| 565 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
1 |
0.0000 |
| 566 |
ANXIETY |
4 |
0.0000 |
| 567 |
SKIN BURNING SENSATION |
1 |
0.0000 |
| 568 |
MOBILITY DECREASED |
1 |
0.0000 |
| 569 |
AGITATION |
1 |
0.0000 |
| 570 |
WEIGHT INCREASED |
3 |
0.0000 |
| 571 |
HYPOAESTHESIA |
2 |
0.0000 |
| 572 |
INCORRECT DOSE ADMINISTERED |
3 |
0.0000 |
| 573 |
DRUG DOSE OMISSION BY DEVICE |
1 |
0.0000 |
| 574 |
ARTHRITIS |
1 |
0.0000 |
| 575 |
CARDIAC FAILURE CONGESTIVE |
1 |
0.0000 |
| 576 |
CONFUSIONAL STATE |
2 |
0.0000 |
| 577 |
GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0000 |
| 578 |
SKIN EXFOLIATION |
1 |
0.0000 |
| 579 |
DEATH |
10 |
0.0000 |
| 580 |
BALANCE DISORDER |
1 |
0.0000 |
| 581 |
INTENTIONAL PRODUCT MISUSE |
1 |
0.0000 |
| 582 |
MUSCULOSKELETAL STIFFNESS |
1 |
0.0000 |
| 583 |
DEVICE ISSUE |
1 |
0.0000 |
| 584 |
SWELLING |
1 |
0.0000 |
| 585 |
PRODUCT USE ISSUE |
2 |
0.0000 |
| 586 |
BLOOD GLUCOSE INCREASED |
2 |
0.0000 |
| 587 |
MALIGNANT NEOPLASM PROGRESSION |
1 |
0.0000 |
| 588 |
HAEMOGLOBIN DECREASED |
1 |
0.0000 |
| 589 |
OVERDOSE |
2 |
0.0000 |
| 590 |
INFLUENZA |
1 |
0.0000 |
| 591 |
ASTHMA |
1 |
0.0000 |
| 592 |
RHEUMATOID ARTHRITIS |
1 |
0.0000 |
| 593 |
MUSCULAR WEAKNESS |
1 |
0.0000 |
| 594 |
DEPRESSION |
2 |
0.0000 |
| 595 |
GENERAL PHYSICAL HEALTH DETERIORATION |
1 |
0.0000 |
| 596 |
JOINT SWELLING |
1 |
0.0000 |
| 597 |
EMOTIONAL DISTRESS |
1 |
0.0000 |
| 598 |
LOSS OF CONSCIOUSNESS |
1 |
0.0000 |
| 599 |
RENAL FAILURE |
1 |
0.0000 |
| 600 |
PRODUCT QUALITY ISSUE |
1 |
0.0000 |
| 601 |
CONDITION AGGRAVATED |
2 |
0.0000 |
| 602 |
CEREBROVASCULAR ACCIDENT |
1 |
0.0000 |
| 603 |
PRODUCT USE IN UNAPPROVED INDICATION |
1 |
0.0000 |
| 604 |
DRUG INEFFECTIVE |
1 |
0.0000 |